Current and historical daily PE Ratio for Cochlear Ltd (
) from 2016 to Jun 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cochlear stock (HAM:OC5) PE ratio as of Jun 15 2024 is 60.8.
More Details
Cochlear Ltd (HAM:OC5) PE Ratio (TTM) Chart
Cochlear Ltd (HAM:OC5) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1253
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Cochlear PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-15 | 60.9 | 2024-04-12 | 59.4 |
2024-06-14 | 60.9 | 2024-04-11 | 59.3 |
2024-06-13 | 61.2 | 2024-04-10 | 59.3 |
2024-06-12 | 61.0 | 2024-04-09 | 59.0 |
2024-06-11 | 61.0 | 2024-04-08 | 60.4 |
2024-06-10 | 61.4 | 2024-04-05 | 60.4 |
2024-06-07 | 61.7 | 2024-04-04 | 61.7 |
2024-06-06 | 61.1 | 2024-04-03 | 60.8 |
2024-06-05 | 61.0 | 2024-04-02 | 61.9 |
2024-06-04 | 59.6 | 2024-03-28 | 62.0 |
2024-06-03 | 60.0 | 2024-03-27 | 61.9 |
2024-05-31 | 60.4 | 2024-03-26 | 61.5 |
2024-05-30 | 59.6 | 2024-03-25 | 61.9 |
2024-05-29 | 58.7 | 2024-03-22 | 60.8 |
2024-05-28 | 60.0 | 2024-03-21 | 60.7 |
2024-05-27 | 60.5 | 2024-03-20 | 60.3 |
2024-05-24 | 59.7 | 2024-03-19 | 60.3 |
2024-05-23 | 60.0 | 2024-03-18 | 61.1 |
2024-05-22 | 59.3 | 2024-03-15 | 60.5 |
2024-05-21 | 59.5 | 2024-03-14 | 62.0 |
2024-05-20 | 59.9 | 2024-03-13 | 61.3 |
2024-05-17 | 61.8 | 2024-03-12 | 61.5 |
2024-05-16 | 63.4 | 2024-03-11 | 61.8 |
2024-05-15 | 62.0 | 2024-03-08 | 63.1 |
2024-05-14 | 60.7 | 2024-03-07 | 61.8 |
2024-05-13 | 60.3 | 2024-03-06 | 61.7 |
2024-05-10 | 59.8 | 2024-03-05 | 61.0 |
2024-05-09 | 60.2 | 2024-03-04 | 61.8 |
2024-05-08 | 61.4 | 2024-03-01 | 61.7 |
2024-05-07 | 61.2 | 2024-02-29 | 64.1 |
2024-05-06 | 60.5 | 2024-02-28 | 63.2 |
2024-05-03 | 60.0 | 2024-02-27 | 63.0 |
2024-05-02 | 59.0 | 2024-02-26 | 63.8 |
2024-04-30 | 60.3 | 2024-02-23 | 63.6 |
2024-04-29 | 60.4 | 2024-02-22 | 62.9 |
2024-04-26 | 59.6 | 2024-02-21 | 63.0 |
2024-04-25 | 59.2 | 2024-02-20 | 61.0 |
2024-04-24 | 59.3 | 2024-02-19 | 60.6 |
2024-04-23 | 59.6 | 2024-02-16 | 61.5 |
2024-04-22 | 59.4 | 2024-02-15 | 61.0 |
2024-04-19 | 57.8 | 2024-02-14 | 60.5 |
2024-04-18 | 58.4 | 2024-02-13 | 59.2 |
2024-04-17 | 58.6 | 2024-02-12 | 59.2 |
2024-04-16 | 58.2 | 2024-02-09 | 59.1 |
2024-04-15 | 59.0 | 2024-02-08 | 56.1 |
Cochlear Ltd (HAM:OC5) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Cochlear Ltd Cochlear Ltd logo](https://static.gurufocus.com/logos/0C00000LGV.png?14)
Cochlear Ltd
NAICS : 339113
ISIN : AU000000COH5
Share Class Description:
HAM:OC5: Ordinary SharesDescription
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.